Intimation of appointment of RPR & Associates as Secretarial Auditor of the Company.
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aurobindo Pharma has announced a change in its secretarial auditor. M/s. MRR & Associates resigned effective May 22, 2026, citing health issues of its sole proprietor as the reason. The Board of Directors has appointed M/s. RPR & Associates as the new Secretarial Auditor for a term of five consecutive years from FY 2026-27 to FY 2030-31, subject to shareholder approval at the ensuing AGM. RPR & Associates is a peer-reviewed firm of company secretaries with expertise in corporate laws, SEBI Regulations, and FEMA Regulations.
The mid-term resignation of the secretarial auditor due to health reasons of its sole proprietor is unusual but appears to be a routine change. The appointment of a new auditor with a long 5-year term suggests continuity planning. No direct impact on stock price expected as this is an administrative/governance change.